Form 8-K Syndax Pharmaceuticals For: Jun 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- CAE agrees to sell Flightscape unit to SITA for $500 million
Syndax raises $250 million through convertible notes offering
June 10, 2026 5:08 PM EDTSyndax Pharmaceuticals (NASDAQ: SNDX) completed a private placement of $250 million in convertible senior notes on June 10, according to a company filing. The 2.25% convertible senior notes are due in 2031.
The pharmaceutical company received net proceeds of approximately $243 million after deducting placement agent fees and offering... More



